Rivera E - Search Results

1

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.

Booser DJ, Esteva FJ, Rivera E, Valero V, Esparza-Guerra L, Priebe W, Hortobagyi GN. Booser DJ, et al. Among authors: rivera e. Cancer Chemother Pharmacol. 2002 Jul;50(1):6-8. doi: 10.1007/s00280-002-0464-0. Epub 2002 May 21. Cancer Chemother Pharmacol. 2002. PMID: 12111105 Clinical Trial.

2

Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer.

Rivera E, Valero V, Esteva FJ, Syrewicz L, Cristofanilli M, Rahman Z, Booser DJ, Hortobagyi GN. Rivera E, et al. Cancer Chemother Pharmacol. 2002 Apr;49(4):299-302. doi: 10.1007/s00280-001-0405-3. Epub 2001 Dec 18. Cancer Chemother Pharmacol. 2002. PMID: 11914909

3

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Buzdar AU, Singletary SE, Valero V, Booser DJ, Ibrahim NK, Rahman Z, Theriault RL, Walters R, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD, Strom E, Thomas E, Hunt K, Ames F, Berry D, Hortobagyi GN. Buzdar AU, et al. Among authors: rivera e. Clin Cancer Res. 2002 May;8(5):1073-9. Clin Cancer Res. 2002. PMID: 12006521 Clinical Trial.

4

Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma.

Rivera E, Valero V, Cristofanilli M, Frye DK, Booser DJ, Rosales MM, Hortobagyi GN. Rivera E, et al. Cancer. 2002 May 1;94(9):2321-6. doi: 10.1002/cncr.10488. Cancer. 2002. PMID: 12015755 Free article. Clinical Trial.

5

Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.

Esmaeli B, Hortobagyi GN, Esteva FJ, Booser D, Ahmadi MA, Rivera E, Arbuckle R, Delpassand E, Guerra L, Valero V. Esmaeli B, et al. Among authors: rivera e. Ophthalmology. 2002 Jun;109(6):1188-91. doi: 10.1016/s0161-6420(02)00989-2. Ophthalmology. 2002. PMID: 12045065 Clinical Trial.

6

A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.

Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: rivera e. Clin Cancer Res. 2002 Nov;8(11):3360-8. Clin Cancer Res. 2002. PMID: 12429622 Clinical Trial.

7

A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma.

Esteva FJ, Rivera E, Cristofanilli M, Valero V, Royce M, Duggal A, Colucci P, DeJager R, Hortobagyi GN. Esteva FJ, et al. Among authors: rivera e. Cancer. 2003 Sep 1;98(5):900-7. doi: 10.1002/cncr.11557. Cancer. 2003. PMID: 12942555 Free article. Clinical Trial.

8

Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.

Rivera E, Valero V, Arun B, Royce M, Adinin R, Hoelzer K, Walters R, Wade JL 3rd, Pusztai L, Hortobagyi GN. Rivera E, et al. J Clin Oncol. 2003 Sep 1;21(17):3249-54. doi: 10.1200/JCO.2003.03.111. J Clin Oncol. 2003. PMID: 12947059 Clinical Trial.

9

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.

Pusztai L, Zhen JH, Arun B, Rivera E, Whitehead C, Thompson WJ, Nealy KM, Gibbs A, Symmans WF, Esteva FJ, Booser D, Murray JL, Valero V, Smith TL, Hortobagyi GN. Pusztai L, et al. Among authors: rivera e. J Clin Oncol. 2003 Sep 15;21(18):3454-61. doi: 10.1200/JCO.2003.02.114. J Clin Oncol. 2003. PMID: 12972520 Clinical Trial.

10

A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancer.

Blakely LJ, Buzdar A, Chang HY, Frye D, Theriault R, Valero V, Rivera E, Booser D, Kuritani J, Tsuda M. Blakely LJ, et al. Among authors: rivera e. Clin Cancer Res. 2004 Aug 15;10(16):5425-31. doi: 10.1158/1078-0432.CCR-04-0321. Clin Cancer Res. 2004. PMID: 15328180 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

762 results

Search Page

Filters